Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Sample Handling

Sample Handling

Transportation of samples from the collection point to the laboratory, as well as storage and preservation techniques, are crucial for maintaining sample integrity and ensuring accurate and reliable test results.
Samples should be transported carefully from collection points to the laboratory. They should be properly sealed and clearly labeled to prevent cross-contamination. To preserve the sample integrity, optimal temperature conditions during transport are essential. This could involve using...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Rapid-Screening Differential Scanning Calorimetry for siRNA Duplex Thermal Analysis in Pharmaceutical Drug Development.

Analytical chemistry·2026

Same author

Perioperative risk factors for short- and long-term respiratory morbidity in patients with esophageal atresia.

Journal of pediatric surgery·2026

Same author

SMARCA2 PROTAC-dendrimer conjugates for the treatment of non-small cell lung cancer.

Journal of pharmaceutical sciences·2026

Same author

Management of postoperative leaks and infections in patients with esophageal atresia.

Seminars in pediatric surgery·2026

Same author

Genetic Risk, Healthy Lifestyle, and Risk Stratification for Diverticulitis.

Journal of the American College of Surgeons·2026

Same author

Building Practice-Ready Nurses: Measuring Competency From the First Semester.

Nurse educator·2026

Search research articles

Related Experiment Video

Updated: May 12, 2026

Whole Animal Perfusion Fixation for Rodents

Whole Animal Perfusion Fixation for Rodents

Published on: July 30, 2012

Drug Development Considerations for Additives to Organ Preservation Solutions.

Matthew O'Brien Laramy¹, Jamie Robinson², C J Venkatramani¹

¹Synthetic Molecule Pharmaceutical Sciences, Genentech, Inc., South San Francisco, CA.

Transplantation

|October 8, 2024

Summary

Developing novel therapeutic agents for organ preservation solutions requires a clear strategy. This approach adapts existing parenteral drug development expectations for organ transplantation, addressing regulatory gaps for improved outcomes.

More Related Videos

Bulk Droplet Vitrification for Primary Hepatocyte Preservation

Bulk Droplet Vitrification for Primary Hepatocyte Preservation

Published on: October 25, 2019

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Published on: March 4, 2021

Related Experiment Videos

Last Updated: May 12, 2026

Whole Animal Perfusion Fixation for Rodents

Whole Animal Perfusion Fixation for Rodents

Published on: July 30, 2012

Bulk Droplet Vitrification for Primary Hepatocyte Preservation

Bulk Droplet Vitrification for Primary Hepatocyte Preservation

Published on: October 25, 2019

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Published on: March 4, 2021

Area of Science:

Pharmacology and Drug Development
Transplantation Medicine
Regulatory Science

Background:

Novel therapeutic agents in organ preservation solutions offer potential benefits for transplant recipients.
Unclear development expectations and limited regulatory guidance hinder the advancement of these agents.
Existing strategies for parenteral drugs provide a foundation, but require adaptation for organ preservation applications.

Purpose of the Study:

To articulate a drug development strategy for novel therapeutic agents in organ preservation solutions.
To address the unmet needs and enhance outcomes in organ transplantation.
To provide considerations for justified deviations from standard parenteral drug development.

Main Methods:

Leveraging development expectations for parenteral drug products (e.g., intravenous administration).
Comparing the proposed strategy with existing US Food and Drug Administration (FDA) regulatory guidance.
Drawing upon internal program experience from Genentech for kidney transplantation.

Main Results:

A comprehensive drug development strategy tailored for organ preservation solutions has been proposed.
Potential areas for clarification in regulatory guidance have been identified.
The strategy considers adaptations for unique aspects of organ preservation compared to conventional parenteral routes.

Conclusions:

A defined strategy can guide the development of novel therapeutic agents for organ preservation.
Addressing regulatory ambiguities is crucial for advancing transplantation medicine.
This framework, based on internal experience, can facilitate future development programs.